[Current treatment of thoracic oesophageal carcinoma (author's transl)].
Always severe and increasingly frequent carcinoma of the thoracic oesophagus now ranks among the most worrying malignancies. However, the authors' experience concur with recent publications to demonstrate that an a priori pessimistic attitude is no longer justified. The considerable progress achieved in pre- and post-operative care and surgical techniques has reduced to 10% the operative mortality rate and has made surgery the best prospect of comfortable and, possibly, prolonged survival. Radiotherapy and chemotherapy still have a place in the treatment, either alone when surgery is contra-indicated or combined with surgical excision.
D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000601:surgery*; D004938:Esophageal Neoplasms / Q000532:radiotherapy / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D011300:Preoperative Care; D012140:Respiratory Tract Diseases / Q000209:etiology; D013909:Thorax
Traitement actuel des cancers de l'oesophage thoracique.